Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

24%

Beneficial ownership of this reported class.

Shares

57,848,357 shares

Shares beneficially owned as disclosed.

Event date

27 Jan 2025

Date tied to the ownership event or amendment.

Accepted by SEC

28 Jan 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
LCTX
Shares outstanding
236,115,743 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
28 Jan 2025, 20:07:41 UTC
Event date
27 Jan 2025
Next SEC filing
14 Nov 2025
Source filing
View source filing

Key filing fact

BROADWOOD PARTNERS, L.P. disclosed 24% ownership in Lineage Cell Therapeutics, Inc. Common Shares, no par value (LCTX) on 27 Jan 2025.

Key facts

  • BROADWOOD PARTNERS, L.P. filed SCHEDULE 13D/A for Lineage Cell Therapeutics, Inc. Common Shares, no par value (LCTX).
  • Disclosed ownership: 24%.
  • Date of event: 27 Jan 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 28 Jan 2025, 20:07.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (3)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
BROADWOOD PARTNERS, L.P. 24% 57,455,729 0 57,455,729 /s/ Neal C. Bradsher* Neal C. Bradsher/President of Broadwood Capital, Inc. 0001278386
BROADWOOD CAPITAL, INC. 24% 57,455,729 0 57,455,729 /s/ Neal C. Bradsher* Neal C. Bradsher/President 0001278387
NEAL C. BRADSHER 24% 57,848,357 392,628 57,455,729 /s/ Neal C. Bradsher* Neal C. Bradsher 0001278388
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .